-
Moxifloxacin (Avelox), a member of the fluoroquinolone class of antibacterial agents, possesses a broad spectrum of bacterial coverage, including both gram-positive and gram-negative microorganisms.1 Moxifloxacin also offers some coverage against anaerobic bacteria.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
The Bush administrations plan to immunize half a million health care workers against the smallpox virus is meeting increasing resistance. As of the last press telebriefing by the Centers for Disease Control and Prevention (CDC) in Atlanta on Feb. 6, the agency had shipped 204,600 doses of vaccine to 40 states or counties that had requested it. The CDC, however, had documentation of fewer than 700 people in 16 jurisdictions being vaccinated in the first two weeks of the program.
-
The Bush administrations latest try at proposing a Medicare drug discount plan was shot down by a federal judge Jan. 29. Now the administration says it may turn to Congress for help.
-
The following drugs are in various stages of clinical studies and trials.
-
-
Recent outbreaks of acute gastroenteritis on land and at sea have occurred and are due to a predominant strain of norovirus, provisionally called Farmington Hills strain. This strain is similar to a common type strain that circulated worldwide in 1995-1997, and it may have characteristics that increase person-to-person transmissibility.
-
Fourteen cases of measles occurred among children adopted from China, their family members, and a caretaker during February-March 2001. Internationally adopted children may not be adequately immunized against measles and other routine childhood diseases.
-
An excellent review was published in Clinical Infectious Diseases on the fungal infections acquired during recent travel abroad. It informs and updates practitioners about the epidemiology, clinical manifestations, diagnosis, prevention, and treatment of the most common mycoses among travelers, including histoplasmosis, coccidioidomycosis, and penicilliosis.
-
Recent cases of hepatitis E in Europe demonstrate that this illness is not limited to developing countries with limited hygiene. An outbreak in Pakistan shows that secondary person-to-person spread is unusual despite primary attack rates of approximately 15% in young adults.
